Overview
Oregon is a leader in promoting healthcare price transparency with a state-run APCD, Oregon All Payer All Claims Database (APAC), and comprehensive mandatory reporting statues for hospitals and other facilities (see 2017 use case document). Oregon is also experimenting with health delivery and payment reform, directing various state agencies to conduct studies on the feasibility of alternative health care delivery financing and coordinated care models that reward quality over volume of patients.
In 2019, the Oregon Legislature is focusing on fighting the rising cost of prescription drugs. With more than 25 bills introduced which touch on pharmaceuticals, Oregon is considering a wide range of solutions, including importing drugs wholesale from Canada (HB 2689), reviewing prices and establishing price caps (HB 2696), reimbursing patients for overly expensive drugs (HB 2424), and publishing drug plans (HB 2692). There is also a Democratic bill in the Senate which would establish a single payer system (SB 770), and a bill which prohibits surprise balance billing (HB 2701).
In the 2018 legislative term, Oregon enacted the “Prescription Drug Price Transparency Act” (HB4005), which is fairly similar to what has become law in a few other states. When the price of a medicine rises more than 10 percent, a drug maker must report the reasons to the Oregon Department of Consumer and Business Services, including information about cost of production, marketing and research. Manufacturers face civil penalties of up to $10,000 per day for failing to comply. In addition to mandating new disclosures by drugmakers and insurers, the new law creates a task force that will develop a strategy for greater transparency across the entire supply chain of pharmaceutical products.
The State Database
The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare.
LEGISLATION: The Database of State Laws Impacting Healthcare Cost and Quality (SLIHCQ), created by The Source on Healthcare Price & Competition and Catalyst for Payment Reform, catalogues state legislation governing price transparency, provider market power, provider payment, provider networks, and benefit design. The database also includes pharmaceutical legislation beginning in the 2017-2018 legislative session. *Note: Current legislative session bill updates are ongoing. Check back weekly for updates.
LITIGATION: The Source tracks major litigation and antitrust enforcement action by federal entities (FTC or DOJ), state attorney generals, and private parties in the main provider and insurer markets, particularly legal challenges of healthcare consolidation and anticompetitive contract provisions. Additionally, the database contains major pharmaceutical cases including legislation challenges and significant appellate cases.
Search the database across all jurisdictions on the State Overview page, or view and filter existing legislation or litigation on individual state pages. The database allows customized search and filter by keyword, status, and/or key issue category. *Multiple filter/selections enabled. Click here for User Guide.

Introduced: 2019 Status: Inactive / Dead
Allows individuals who do not qualify for medical assistance or premium tax credits under Affordable Care Act to enroll in coordinated care organizations by paying premiums that cover actuarial value of health services. Requires Oregon …
HB 2010 – Oregon
Introduced: 2019 Status: Enacted
Extends Oregon Reinsurance Program and authorizes Department of Consumer and Business Services to request extension of waiver for state innovation. Authorizes department to change attachment point or coinsurance rate for program under specified conditions. Extends …
HB 2012 – Oregon
Introduced: 2019 Status: Inactive / Dead
Allows individuals who do not qualify for medical assistance or premium tax credits under Affordable Care Act to enroll in coordinated care organizations by paying premiums that cover actuarial value of health services. Requires Oregon …
HB 2091 (see companion bill SB 129) – Oregon
Introduced: 2019 Status: Inactive / Dead
Allows licensed optometrists to use telehealth to provide telemedicine to patients. Defines “telehealth” and “telemedicine.” Declares emergency, effective on passage.
HB 2185 – Oregon
Introduced: 2019 Status: Enacted
Imposes new requirements on pharmacy benefit managers registered in this state.
Next | See all Legislation Records
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Introduced: 2019 Status: Enacted
Extends Oregon Reinsurance Program and authorizes Department of Consumer and Business Services to request extension of waiver for state innovation. Authorizes department to change attachment point or coinsurance rate for program under specified conditions. Extends …
HB 2185 – Oregon
Introduced: 2019 Status: Enacted
Imposes new requirements on pharmacy benefit managers registered in this state.
HB 2267 – Oregon
Introduced: 2019 Status: Enacted
Requires coordinated care organization to conduct community health assessment and adopt community health improvement plan in collaboration with local public health authorities and hospitals. Requires Oregon Health Authority to report to interim committees of Legislative …
HB 2447 – Oregon
Introduced: 2019 Status: Enacted
Requires Director of the Oregon Health Authority to provide forum for all vertically integrated, nonprofit health care systems in Oregon to collaborate to envision health care delivery system for Oregon’s future. Requires supervision of collaboration …
HB 2658 – Oregon
Introduced: 2019 Status: Enacted
Requires manufacturer of prescription drugs to report to Department of Consumer and Business Services planned increase in price of certain prescription drugs at least 60 days before date of increase. Provides exceptions.
Next | See all Legislation Records
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
District Court: District of Idaho Status: Decided
In March 2013, the FTC and the Idaho Attorney General filed a joint complaint challenging the merger betweenSt. Luke’s Health System, Idaho’s largest health system, …
In re: Suboxone Antitrust Litigation (State of Wisconsin, et al. v. Indivior Inc, et al.) – Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Hampshire, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Dakota, Tennessee, Utah, Virginia, Washington, West Virginia, Wisconsin
District Court: E.D. Pennsylvania Status: Pending
In September 2016, 35 state attorneys general and the District of Columbia brought a multi-district case against pharmaceutical manufacturer Indivior, MonoSol RX et al., alleging …
In Re: Generic Pharmaceuticals Pricing Antitrust Litigation – Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin
District Court: Eastern District of Pennsylvania Status: Pending
Plaintiffs are attorney generals from 48 states, Puerto Rico, and the District of Columbia, as well as classes of private plaintiffs that filed an antitrust …
See all Litigation Records
Additional Resources
LEGISLATIVE CALENDAR
Oregon’s current legislative term runs from 1/22/2019 – 6/30/2019. Oregon’s next legislative term will begin in 2020.2017 – 2019 BUDGET
The biennium budget begins on July 1 of an odd-numbered year and ends on June 30 of the next odd-numbered year. The Governor is expected to sign the 2019-2021 Budget at the end of June 2019. To view the Governor’s most recent proposal on Oregon’s health spending, click here.ANTITRUST ENFORCEMENT
- Oregon was one of 16 states to file an amicus brief supporting the FTC’s winning position in the Ninth Circuit appeal of St. Luke’s Health Care Sys. v. FTC, No. 14-35173 (March 7, 2014), decided February 10, 2015. The States’ brief stated that the acceleration of health care costs due to the growth of large health care provider systems had become a matter of grave concern for the states.
KEY RESOURCES
Coverage

September 13, 2018


July 24, 2018

July 17, 2018

July 3, 2018